|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.91 USD | +0.54% |
|
+5.21% | +69.24% |
| 06-10 | Moderna, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03:20 PM | |
| 06-09 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| Market Cap | 19.8B 17.1B 15.76B 14.75B 27.65B 1,882B 28.08B 186B 72.56B 916B 74.32B 72.74B 3,172B | P/E Ratio 2026 * |
-5.77x | P/E Ratio 2027 * | -10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 16.24B 14.03B 12.93B 12.1B 22.68B 1,544B 23.03B 153B 59.52B 752B 60.96B 59.67B 2,602B | EV / Sales 2026 * |
7.76x | EV / Sales 2027 * | 6.98x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Moderna, Inc.
| 1 day | +0.54% | ||
| 1 week | +5.21% | ||
| Current month | +5.76% | ||
| 1 month | -1.01% | ||
| 3 months | -5.04% | ||
| 6 months | +69.42% | ||
| Current year | +69.24% |
| 1 week | 45.4 |  | 51.75 |
| 1 month | 43.9 | | 51.9 |
| Current year | 29.81 | | 59.55 |
| 1 year | 22.28 | | 59.55 |
| 3 years | 22.28 | | 170.47 |
| 5 years | 22.28 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 62 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-05 | Fiscal year | Chief Financial Officer | 29,301 | 0.0074% | ||
| 06-05 | Fiscal year | General Counsel | 29,301 | 0.0074% | ||
| 06-01 | Fiscal year | Chairperson | 23,052 | 0.0058% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.54% | +5.21% | +87.14% | -61.00% | 19.8B | |
| +0.11% | -3.67% | +15.66% | -20.23% | 62.28B | |
| +1.44% | +5.33% | +68.19% | +222.27% | 60.59B | |
| +0.70% | +29.50% | +29.50% | +29.50% | 39.55B | |
| +0.26% | +9.80% | -54.99% | -65.15% | 36.8B | |
| +0.05% | +2.41% | +53.12% | -34.32% | 29.53B | |
| +0.65% | +6.01% | +60.19% | +75.19% | 21.68B | |
| +4.80% | -0.20% | -5.27% | +115.05% | 16.96B | |
| +0.18% | -1.66% | +54.11% | +100.91% | 16.16B | |
| +0.55% | +9.84% | +145.12% | +240.77% | 13.13B | |
| Average | +0.93% | +3.78% | +45.28% | +60.30% | 31.65B | |
| Weighted average by Cap. | +0.79% | +3.27% | +36.46% | +54.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.09B 1.81B 1.67B 1.56B 2.92B 199B 2.97B 19.68B 7.67B 96.89B 7.86B 7.69B 335B | 2.51B 2.17B 2B 1.87B 3.51B 239B 3.56B 23.61B 9.2B 116B 9.43B 9.23B 402B |
| Net income | -3.4B -2.94B -2.71B -2.54B -4.75B -324B -4.83B -31.99B -12.47B -157B -12.77B -12.5B -545B | -1.84B -1.59B -1.46B -1.37B -2.57B -175B -2.61B -17.29B -6.74B -85.12B -6.91B -6.76B -295B |
| Net Debt | -3.56B -3.07B -2.83B -2.65B -4.97B -338B -5.05B -33.45B -13.04B -165B -13.36B -13.07B -570B | -2.27B -1.96B -1.81B -1.69B -3.17B -216B -3.22B -21.36B -8.33B -105B -8.53B -8.35B -364B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 49.91 $ | +0.54% | 5,081,172 |
| 11/06/26 | 49.64 $ | +7.94% | 6,196,215 |
| 10/06/26 | 45.99 $ | -3.65% | 4,217,036 |
| 09/06/26 | 47.73 $ | +0.27% | 5,080,455 |
| 08/06/26 | 47.60 $ | +0.34% | 3,994,555 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition